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Acute worsening of renal function during episodes of macroscopic
hematuria in IgA nephropathy. The appearance of renal failure during
episodes of macroscopic hematuria (EMH) in IgA nephropathy (IgAN)
has been described as very unusual. The results of a prospective
investigation on the effect of EMH on renal function in IgAN are
presented. During a 3-year period, 29 episodes of EMH occurring in 21
patients with IgAN have been studied. A derangement of renal function
(increase of serum creatinine by more than 0.5 mg/dl) was observed in
ii episodes (37.9%) with peak creatinine values ranging from 1.2 to 6.7
mgldl. The worsening of renal function was accompanied by a longer
duration of EMH (4.8 1.3 vs. 3.5 1.5 days; P < 0.05) but not by
arterial hypertension or edema. A complete recovery of renal function
was observed in every patient 1 to 2 months after the start of EMH. The
histological survey disclosed that the decrease of renal function cone-
lated closely with the presence of red blood cell casts in as much as 50%
of the tubular lumen and with findings of tubular necrosis. We conclude
that a worsening of renal function can be observed frequently during the
EMH. Tubular damage and obstruction by red blood cell casts may play
a significani role in the pathogenesis of this complication.
Degradation aigue de Ia fonction rénale pendant les episodes d'héma-
tune macroscopique au cours de Ia néphropathie a IgA. La survenue
d'une insuflisance rénale pendant les episodes d'hématurie macrosco-
pique (EMil) lors de nephropathie a IgA (IgAN) a éte considérée
comme trés inhabituelle. Les résultats d'une exploration prospective de
l'effet des EMH sur Ia fonction rénale lors de l'IgAN sont présentés. Au
cours d'une période de 3 ans, 29 episodes d'EMH survenant chez 21
malades atteints d'IgAN ont Cté étudiés. Une alteration de Ia fonction
rénale (augmentation de Ia créatininémie de plus de 0,5 mgldl) a été
observée lors de 11 episodes (37,9%) avec des valeurs maximales de
créatinine comprises entre 1,2 et 6,7 mg/dl. L'altération de Ia fonction
rénale s'accompagnait d'une plus grande durée d'EMH (4,8 1,3
contre 3,5 l,Sjours; P <0,05) mais non d'une hypertension artérielle,
ni d'oedémes. Une récupération complete de Ia fonction rénale a été
observée dans chaque malades 1 a 2 mois apres le debut de I'EMH.
L'étude histologique a montré que Ia diminution de Ia fonction rénale
était positivement corrélée a Ia presence de cylindres hematiques dansjusqu'à 50% des lumières tubulaires et a des aspects de nécrose
tubulaire. Nous concluons qu'une degradation de Ia fonction rénale
peut souvent être observée pendant les EMH. Les lesions et l'obstruc-
tion tubulaires par des cylindres hematiques pourraient jouer un role
significatif dans Ia pathogenie de cette complication.
Usually, the diagnosis of IgA nephropathy (IgAN) is based on
the finding of predominant mesangial deposits of IgA, fre-
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quently associated with similar deposits of IgG and C3, in the
absence of systemic and liver diseases [1—3]. Its frequency of
presentation is variable [1, 4—7], but in Spain it constitutes the
most common type of primary glomerulonephritis. The progno-
sis of the disease was considered initially as benign, albeit a
longer follow-up of the patients has shown a relatively high
development of progressive renal failure [5—111.
The typical clinical presentation is as episodes of macro-
scopic hematuria (EMH), coincidental in many patients with
infections of the upper respiratory tract [6, 11, 12]. EMH
usually are considered harmless for the kidney function. Nev-
ertheless, in some isolated cases, the development of acute
renal failure (ARF) during EMH has been described [1, 6, 9,
13—17].
During the last 3 years we have studied the influence of EMH
on renal function in a patient group diagnosed as having IgAN.
An unexpectedly high incidence of reversible acute renal failure
has been found that correlated with the histological finding of
tubular necrosis and tubular obstruction by red blood cell
(RBC) casts.
Methods
A prospective study was designed to evaluate the influence of
EMH on the renal function of patients diagnosed as having
IgAN. The diagnosis of IgAN was based on the finding in a
renal biopsy of predominant mesangial granular immunofluore-
scent deposits of IgA, in the absence of any manifestation of
systemic lupus erythematosus, Henoch-SchOnlein purpura,
vasculitis, acute or chronic hepatitis, cirrhosis, alcoholism, and
Alport syndrome.
Those patients previously diagnosed of IgAN were advised to
come to our hospital whenever EMH appeared. In those
patients presenting with EMH and with a clinical history plus
data from an analytical survey suggestive of IgAN, a renal
biopsy was performed on admittance. When the pathology
study showed the characteristics of IgAN, the patients were
included in the study. No patient was biopsied again during an
EMH.
With this criteria we studied a total of 29 EMH occurring in
21 patients (two patients presented with three EMH and four
patients with two EMH). The initial study, performed in every
patient in the first 72 hr after the initiation of EMH, included the
following data: age, sex, existence of associated infection, day
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P A 29/M 6 2.9 5 9 60 1.1
2 A 29/M 5 1.9 2.4 4 30 1,23 B 23/M 6 3.2 6.7 6 70 1.2
4 B 24/M 4 0.8 1.6 3 15 1.1
5 C 25/M 7 2.5 6.1 10 45 1.16 D 25/M 4 1.8 3.4 4 30 0.97 F 30/M 5 1.3 2.3 7 15 1.2
8 F 41/M 3 1.1 1.9 10 20 1.29 G 18/M 3 0.9 1.6 7 15 1.1
10 H 12/M 5 0.7 1.6 6 15 0.7
iia I 12/F 5 0.6 1.2 3 20 0.8
Abbreviations: SCr I, initial serum creatinine (measured in the first 72 hr after a MH appearance; SCr M, maximal serum creatinine observed;
EMH, episodes of macroscopic hematuria.
a A renal biopsy was performed during an episode of EMH.
b The interval is between the onset of FMH and SCr M.
of macroscopic hematuria appearance, fever, edema, blood
pressure, and intake of any medication. The analytical survey
included: hematocrit, hemoglobin, total and differential
leukocyte count, serum creatinine (SCr), sodium, potassium,
chloride, bicarbonate, calcium, phosphate, uric acid, glucose,
total proteins, albumin, creatine phosphokinase, lactic dehy-
drogenase, bilirubin, serum aspartate aminotransferase
(SGOT), serum glutamic pyruvic transaminase (SGPT), and C3
and C4 fractions of complement; in urine, 24-hr proteinuria and
sediment (Addis count).
During the follow-up, SCr was measured every 3 to 4 days in
the first 2 weeks after an EMH. Once weekly, the complete
analytical survey cited above, excluding C3 and C4, was
performed during the first month. Thereafter, if necessary, the
patients were reviewed every other week. Patients were admit-
ted to the hospital whenever SCr reached a value above 3 mg/dl.
This parameter was measured daily until a decline was ob-
served. Thereafter, the follow-up continued at the outpatient
clinic. In the ambulatory patients, the performance of creatinine
clearance was discarded because we found the 24-hr urine
collection frequently incorrect.
The existence of derangement of renal function during an
EMH was considered whenever SCr increased by a minimum of
0.5 mg/dl or a similar decrement was observed during the
follow-up period in patients older than 15 years. In younger
patients, a variation of SCr in excess of 0.3 mg/dl was consid-
ered to be a change in renal function.
Renal biopsy specimens were studied by light microscopy,
immunofluorescence, and electron microscopy as previously
described [18]. The presence and severity of mesangial prolif-
eration and tubular necrosis was graduated between 0 and + + +
by three different observers. The result expressed is the mean
value of the three. The existence of glomerular crescents and
RBC casts in tubules was expressed as the percentage of
glomeruli or tubules presenting these lesions.
Standard laboratory techniques were used for the measure-
ment of the different parameters. Proteinuria was evaluated by
the method of precipitation with sulphosalicylic acid. The
statistical analysis of the results was performed by means of
Student's t test for unpaired data and by the x2 test.
Results
Twenty-nine EMH were studied in 21 patients with IgAN.
The impairment of renal function was detected in 11 EMH
(37.9%, group 1) observed in nine patients, whereas in the
remaining 19 EMITI (62.1%, group 2), occurring in 15 patients,
normal renal function was the most common finding. The
clinical data during EMH of group 1 are shown in Table 1.
Three patients participated in the results of groups 1 and 2:
Patient A presented with renal failure in two EMH (numbers 1
and 2, Table 1), whereas in a third EMH renal function
remained normal; patient C showed renal failure in only one
(no. 5, Table 1) of three EMH studied; and patient I showed
renal impairment in one (no. 11, Table 1) of her two EMH
studied. Patient B presented renal failure in both of his two
EMH studied (nos. 3 and 4, Table 1),
Ten EMH of the 11 included in group 1 were associated with
acute tonsilitis and one with influenza; in group 2, nine EMH
were associated with acute tonsilitis, three with influenza, and
one with pneumonia. In five EMH of group 2 an associated
infection was not found.
Edema and elevated blood pressure were not noticed in any
of the patients when EMH were studied. Transient oliguria
(diuresis less than 500 ml/24 hr during 2 days) was observed in
only one EMH of group 1 (no. 3, Table 1), during hospital
admittance of the patient. Physical examination was normal in
every patient, and no signs of hydrosaline depletion were
observed in any case. Mean age during EMH was 24.3 8.3
years for group 1 and 20 7.1 years for group 2 (P = NS). The
duration of EMH was 4.8 1.2 days in group 1 and 3.5 1.5
days in group 2 (P < 0.05).
The highest SCr level during the EMH ranged from 1.2 to 6.7
mg/dl (X 3 mg/dl) in group 1; the interval between the beginning
of the EMH and the maximal SCr ranged from 3 to 10 days
(X 6.2 days). The SCr returned to levels below 1.3 mg/dl in
every case over a period of 15 to 70 days after the onset of EMH
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Table 2. Histologic findings in renal biopsy specimens of group 1
Interval between
end of EMH and % of tubules
Duration EMH renal biopsy Mesangial % of glomeruli with RBC Tubular
Patient days days proliferation with crescents casts necrosis Immunofluorescence
A 6 1 ++ 0 35% ++ IgA;C3B 6 4 ++ 15% 40% +++ IgA
D 4 4 + 13% 50% +++ IgA;C3
I 5 1 + 8% 20% + IgA
E 5 12 ++ 3% 5% — IgA;C3
G 3 12 + 0 10% — IgA
a In patients A and B the renal biopsy was performed during the first of the EMH they experienced that was associated with renal insufficiency.
Table 3. Histologic findings in renal biopsy specimens of group 2
Interval between
end of EMH and % of tubules
Duration of EMH renal biopsy Mesangial % of glomeruli with RBC Tubular
Patient days days proliferation with crescents casts necrosis Immunofluorescence
J 4 4 + 0 10% + IgA
K 6 7 ++ 0 5% — IgA;IgG;C3
L 5 6 1- 0 5% + IgA
M 4 2 + 0 10% + IgA
N 6 7 + 0 5% — IgA;C30 3 14 + 0 0% — IgA
P 3 11 + 0 10% + IgA
(see Table 1). The maximal SCr observed during EMH in group
2 ranged from 0.6 to 1.3 mgldl (X 1 mgldl).
Proteinuria was significantly greater during EMH than after it
in every of the 29 EMH studied (1.4 1.1 g/24 hr during EMH,
versus 0.5 0.5 g/24 hr 15 days after EMH: P < 0.0025).
However, no significant difference was found between the two
groups in the amount of proteinuria; proteinuria during EMH
was 1.9 1 g124 hr in group 1 and 1.2 1.1 g/24 hr in group 2
(P = NS). Proteinuria fifteen days after EMH was 0.7 0.6 g/24
hr in group 1 and 0.4 0.4 g/24 hr in group 2 (P = NS).
The examination of urinary sediment during EMH showed
severe hematuria in every case. In addition, RBC casts were
observed in three EMH of group 1, granulous casts in five,
hyaline casts in two, frequent tubular cells in two, moderate
leukocyturia in two, and intense leukocyturia in one. In group
2, RBC casts were observed in three EMH, granulous casts in
two, hyaline casts in one, frequent tubular cells in one, moder-
ate leukocyturia in two, and severe leukocyturia in three. We
did not find eosinophiluria in any patient of the two groups.
No other analytical abnormalities were present, but a very
mild transient anemia in two cases of group 1 with a severe
renal function impairment (nos. 3 and 5 of Table 1), and a slight
and also transient hyperuricemia in the patients with a greater
SCr elevation (nos. 1, 3, and 5, Table 1). These two findings
disappeared as renal function returned to normal in these
patients. No patients with trombopenia, eosinophilia, or
hypoproteinemia were observed. C3 and C4 fractions of com-
plement were normal in every patient.
Antibiotics were administered during eight EMH of group 1
(penicillin in five EMH, ampicillin in one, unknown antibiotics
in two).There was antibiotic treatment (penicillin and ampicil-
un) during ten EMH of group 2.
Histologic findings. A renal biopsy was performed in six
EMH of group 1, between days 6 to 17 after the onset of
macroscopic hematuria (X 10.5 4.5 day), and in seven EMH
of group 2 between days 6 to 17 after the onset of EMH (X 11.7
3.7 day) (P = NS). The most significant pathologic changes
are shown in Tables 2 (group 1) and 3 (group 2).
There were crescents in four biopsy specimens of group 1
although the percentage of glomeruli with crescents was less
than 16% in every case. The glomeruli frequently showed a mild
increase of mesangial matrix and moderate proliferation of
mesangial cells, but occlusion or decreased patency of capillary
lumen were not seen in any case. Capillary walls were normal in
every case. The immunofluorescence showed mesangial gran-
ular deposits of IgA in every case; mesangial granular deposits
of C3 and IgG were seen in five of 13 and one of 13 biopsy
specimens, respectively, without a significant difference be-
tween both groups. No deposits of 1gM, Clq, C4, or fibrinogen
were seen.
Mild isolated interstitial infiltrates were seen in some biopsy
specimens. The most striking histological findings were local-
ized at the tubules. In almost all the biopsy specimens of both
groups, RBC casts in the tubule lumens were found. However,
the percent of tubules filled by RBC casts was higher in biopsy
specimens of group 1 than in biopsy specimens of group 2: 26.6
17.7% versus 6.4 3.7 (P < 0.0025). Particularly, the biopsy
specimens of patients A, B, and D, who had severe impairment
of renal function (see Table 1), showed a 35 to 50% of the
tubules were filled by RBC casts. Many of the tubules with RBC
casts focally showed the following features (Figs. I and 2):
dilatation of the lumen, and degenerative and regenerative
epithelial changes. The degenerative changes consisted of
eosinophilia, hyperchromatism, and nuclear pyknosis. Occa-
sionally, there was vacuolar cytoplasmic degeneration. Those
lesions led to a detachment of necrotic epithelial cells and
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Fig. 1. Tubules with red blood cells (patient D, group 1). On the right,
a portion of a normal glomerulus (G) can be observed. On the left, three
tubules (T) are shown with red blood cells into its lumen. Areas with
vacuolar cytoplasmic degeneration (large arrows) and nuclear pyknosis
(small arrows) are seen. In the tubule on the left, a diminished number
of the lining tubular cells and flattened epithelial cells are seen. (H&E,
x250)
Fig. 2. Tubules (T) filled with red blood cells (patient A, group 1). A
mitosis (large arrow) and several nuclear pyknosis (small arrows) are
seen. (H&E, x250)
desquamation, with a diminished number of the lining tubular
cells. The regenerative changes corresponded to the presence
of flat epithelial cells trying to cover the nude tubular basement
membranes; in addition to that evidence of cell regeneration,
frequent mitotic figures were also seen in the most severely
injured tubules. These findings of tubular damage were local-
ized mainly at the proximal tubules. Its frequency and severity
were greater in biopsy specimens of group 1, accordingly, with
the higher percent of tubules with RBC casts in this group.
Tubules without RBC casts always showed a normal appear-
ance.
Discussion
EMH constitute the main clinical findings in IgAN [6, 11, 12].
They are usually considered as harmless for the kidney, al-
though very little attention has been paid to the state of renal
function during these EMH. Clarkson et al [6] described ARE
as one of the forms of clinical presentation of IgAN in three of
their patients. However, in two of them the ARF was associ-
ated to sepsis and in the other one to malathion intoxication.
Isolated case reports of ARF in patients with IgAN have been
reported [1,9, 13—17]. In the vast majority of these cases, the
renal failure appeared after an EMH. The severity as well as the
duration of ARF was variable; some patients had long-standing
oligoanuria that required dialysis [15]. However, in nearly
every case, the renal function returned to normal values after
the EMH.
To our knowledge, ours is the first description of the real
incidence of renal function worsening during EMH in IgAN. In
11(37.9%) out of 29 EMH studied we observed this complica-
tion. Although the degree of renal function impairment was
slight in most patients, in some patients the SCr reached values
greater than 5 mg/dl. Probably if the measurement of glomerular
filtration rate (GFR) was included, the percentage of decrease
of renal function should have been higher, due to the possibility
of decreases of GFR in the absence of changes of SCr.
Arterial hypertension and edema were absent in every pa-
tient. In one EMH of group 1, transient oliguria was observed
during hospitalization because of a SCr of 6.7 mg/dl (no. 3 of
Table 1). Our cases differ clearly from those in which a nephritic
syndrome, with arterial hypertension, oliguria, and edema,
constitutes the form of presentation of IgAN [1, 6j. Some ARF
patients associated to an EMH in IgAN have shown relapses of
the ARF during other EMH [15}. This is confirmed in our study
through the recurrence of the renal function impairment during
two EMH in two patients (A and B, see Table 1). Nevertheless,
the appearance of renal failure during recurrent EMH is not
constant, as was not shown in patients A, C, and I, who
presented intermittent derangement of renal function.
The longer duration of EMH in group than in group 2 points
to a pathogenic role of macroscopic hematuria in the appear-
ance of renal functional derangement. However, the cause of
this derangement is unknown. It has been described in patients
with IgAN that the finding of glomerular crescents is signifi-
cantly greater in those renal biopsies performed near to an
EMH than in those performed later [3]. Some authors suggest
that the great amount of RBC that pass to the Bowman's space
during a glomerular hematuria could stimulate the epithelial
proliferation, resulting in the formation of crescents [19]. How-
ever, the number of crescents is usually too low to explain the
renal failure by means of this epithelial proliferation [3, 16]. In
our study, renal biopsy specimens of group I showed a greater
frequency of crescents than specimens of group 2 (see Tables 2
and 3). However, the percentage of glomeruli with crescents
was always inferior to 16%. It led us to consider that this
glomerular lesion should not be why renal function worsened
during EMH.
On the other hand, we were impressed by the striking tubular
abnormalities found in renal biopsy specimens from our pa-
tients. Except for one biopsy specimen of group 2, every case
showed RBC casts in the tubular lumens. The percent of
tubules with RBC casts was significantly greater in renal biopsy
specimens of group I. Interestingly, the renal tissue of patients
A, B, and D, who developed a marked increment of their SCr,
showed the highest percent of tubular lumens filled by RBC
casts. In addition to that, signs of tubular epithelial necrosis
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were evident in several biopsy specimens. The finding of this
tubular necrosis (TN) correlates closely with the presence of
RBC casts: Only those tubules with RBC in its lumen showed
signs of TN. Consequently, biopsy specimens of group 1 had a
more frequent and severe degree of TN than those of group 2.
We then conclude that the derangement of renal function
observed in more than one third of EMil can be explained by
the appearance of TN associated with the presence of RBC
casts.
As can be seen in Table 2, a delay in the performance of the
renal biopsy since the initiation of EMH was accompanied by a
lesser degree of TN and by less frequent RBC casts in the
tubules, in patients who had a derangement of renal function
(see patients E and G, Table 2). It is probable that biopsies
taken early are needed to observe the histological damage
induced by the EMH on the renal tubules.
Tubular lesions during EMH in IgAN have not been de-
scribed in published studies, to our knowledge. Only Kincaid-
Smith et al [16] have described tubular lesions similar to those
we have described, in a case of IgAN with ARF following an
EMH. The close correlation that we have observed between
TN and the presence of RBC casts in the lumen, suggests a
causal role for these casts. The cause of the TN could be the
hemoglobin released by the broken RBC [16]. The
nephrotoxicity of hemoglobin remains a controversial issue;
administration of pure hemoglobin did not appear to be
nephrotoxic. However, its administration to volume-depleted
animals is followed by a derangement of renal function [20]. It
also has been shown that hemoglobin, in the presence of acid
urine (pH <5.6), produces hematin, which can be nephrotoxic
[21]. The renal toxicity of hemoglobin could be similar to that of
myoglobin [22]. Moreover, some ARF cases have been de-
scribed that were associated with bouts of paroxysmal noctur-
nal hemoglobinuria [23].
The administration of antibiotics during the EMH of IgAN is
common, due to the frequent association of infectious pro-
cesses, which was noticed in many of our cases. The antibiotics
could have played a role in the appearance of the renal im-
pairment through an acute immunoallergic interstitial nephrop-
athy [24]. However, in any case a rash, eosinophilia, or
eosinophiluria were present. Moreover, no data suggestive of
acute immunoallergic interstitial nephropathy were found in the
renal biopsy specimens, with only mild isolated cellular infil-
trates being present in some specimens. For these reasons, we
think that this possibility can be discarded reasonably.
The long-term prognostic significance of these EMH with
renal function impairment is unknown. It has been suggested
that the evolution to chronic renal failure in IgAN is more
frequent in patients with a clinical history of EMH than in those
without EMH [3], but conclusive evidence of this event is
lacking [9]. In a previous revision of our cases of IgAN, the
presence and the number of EMH did not have prognostic
significance [7]. In all group 1 patients, SCr levels returned to
normal values; however, it could be possible that, after re-
peated EMH, the tubular lesions observed in these patients
produces chronic tubulointerstitial changes, which could play a
role in the development of chronic renal failure in IgAN. In a
similar way, the crescents associated to EMH, can lead to
global sclerosis of the affected glomerulus; although the fre-
quency of these crescents is usually low, the repeated EMH
characteristic of IgAN could have an additive effect, leading to
a significant number of scierosed glomeruli. In fact, it has been
shown that diffuse tubulointerstitial damage and a high percent
of sclerosed glomeruli are nearly constant in the renal biopsy
specimens obtained in patients with IgAN which present ad-
vanced chronic renal failure [1, 11]. These chains of events may
be of special interest, as the prognosis of IgAN is not as
favorable as initially thought [5—11].
If the renal function derangement in these cases of IgAN is a
consequence of the glomerular hematuria through tubular dam-
age, similar events should have a place in other clinical condi-
tions presenting with severe glomerular hematuria. More stud-
ies are required about the effects of glomerular hematuria over
the renal function.
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